News | November 10, 2024
Henkel, Covestro and Quad Industries collaborate for advanced medical wearables based on printed electronics
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
The company uses iPS cells to develop treatments for diseases relating to the kidney
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Partnership to Combine AbbVie's Oncology Expertise with EvolveImmune's Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer
The newly setup entity, Emcutix Biopharmaceuticals Limited, plans to significantly expand Emcure’s offerings
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
Strengthening focus in Alzheimer's disease and neuroscience pipeline
CMG1A46 is an investigational T cell-engager with potential to deeply deplete uncontrolled B cells present in autoimmune diseases such as lupus
Revolf's infertility and miscarriage tests are a new technology that uses blood tests to detect neoself-antibodies
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Subscribe To Our Newsletter & Stay Updated
